The UK’s private GP EHR market is forecasted to grow due to the increasing demand for private healthcare services and advancements in healthcare technology. The integration of AI and wearable technology with EHR systems is expected to boost this growth further. However, privacy concerns and technical issues could limit the adoption of EHR systems.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
